艾锐威特生物制药 AVBP
$13.64 +$1.41 (+11.53%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.52 -0.85%
开盘$12.40
昨收$12.23
当日区间$12.00 – $13.88
成交量1.40M
市值$672.56M
市盈率（TTM）–
股息率–
AVBP 相关新闻
匹配 ArriVent BioPharma 或代码 AVBP 的头条新闻，按最新排序。
- Truist Financial Initiates ArriVent BioPharma(AVBP.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)
- ArriVent BioPharma, Inc. (AVBP) Gets a Buy From Guggenheim
- Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP) 正面
- Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)
- A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $45
- H.C. Wainwright Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Raises Target Price to $47 正面
- Citi Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Cuts Target Price to $40 负面
- Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)
- A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $50
- Analysts Offer Insights on Healthcare Companies: Kyverna Therapeutics, Inc. (KYTX) and ArriVent BioPharma, Inc. (AVBP)
- Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Alterity Therapeutics (ATHE)
- A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $42 to $50
- JonesTrading Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45
- Guggenheim Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45
暂无评论——快来第一个聊聊 AVBP。
登录后参与讨论。